0001237648-20-000071.txt : 20201130 0001237648-20-000071.hdr.sgml : 20201130 20201130155622 ACCESSION NUMBER: 0001237648-20-000071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201127 FILED AS OF DATE: 20201130 DATE AS OF CHANGE: 20201130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aroesty Jason D CENTRAL INDEX KEY: 0001737532 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22427 FILM NUMBER: 201358139 MAIL ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HESKA CORP CENTRAL INDEX KEY: 0001038133 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 770192527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 BUSINESS PHONE: 9704937272 MAIL ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-11-27 0 0001038133 HESKA CORP HSKA 0001737532 Aroesty Jason D 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 0 1 0 0 EVP, International Diagnostics Common Stock 2020-11-27 4 M 0 11460 106.67 A 11460 D Common Stock 2020-11-27 4 M 0 1874 106.67 A 13334 D Common Stock 2020-11-27 4 S 0 10233 126.6812 D 3101 D Common Stock 2020-11-27 4 S 0 3101 127.439 D 0 D Incentive Stock Option (right to buy) 106.67 2020-11-27 4 M 0 1874 0 D 2018-07-25 2028-07-24 Common Stock 1874 937 D Non-Qualified Stock Option (right to buy) 106.67 2020-11-27 4 M 0 11460 0 D 2018-07-25 2028-07-24 Common Stock 11460 5729 D The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.16 to $127.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.16 to $127.855. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected By: Catherine Grassman For: Jason D. Aroesty 2020-11-30